Jefferies Group's GSK Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 13,825 shares of GSK plc (GSK) worth $677,978, representing 0.00% of the portfolio. First purchased in 2022-Q4, this short-term holding has been held for 5 quarters.
Based on 13F filings, Jefferies Group has maintained this position in GSK for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2023, adding 23,503 shares. Largest reduction occurred in Q4 2023, reducing 23,503 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +6,314 | New Buy | 6,314 | $35.14 |
| Q1 2023 | -6,314 | Sold Out | 0 | $0.00 |
| Q3 2023 | +23,503 | New Buy | 23,503 | $36.25 |
| Q4 2023 | -23,503 | Sold Out | 0 | $0.00 |
| Q4 2025 | +13,825 | New Buy | 13,825 | $49.04 |
Jefferies Group's GSK plc Investment FAQs
Jefferies Group first purchased GSK plc (GSK) in Q4 2022, acquiring 6,314 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held GSK plc (GSK) for 5 quarters since Q4 2022.
Jefferies Group's largest addition to GSK plc (GSK) was in Q3 2023, adding 23,503 shares worth $851,984.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 13,825 shares of GSK plc (GSK), valued at approximately $677,978.
As of the Q4 2025 filing, GSK plc (GSK) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in GSK plc (GSK) was 23,503 shares, as reported at the end of Q3 2023.